Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-28
1997-11-04
Venkat, Jyothsan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514829, 514830, 514937, A01N 4316
Patent
active
056840373
ABSTRACT:
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a pharmacologically acceptable carrier. In accordance with the process, a preventively or therapeutically effective amount of the composition is topically administered to a human patient, as required; i.e. for prevention the composition is administered to the area of skin susceptible to exposure to antigen and for treatment the composition is administered to the reaction site.
REFERENCES:
patent: 4362742 (1982-12-01), Sullivan
patent: 5532270 (1996-07-01), Clemente et al.
Cecil: Textbook of Medicine, 20th Ed., vol. 2, Bennett et al. eds., W.B. Saunders Co. (Philadelphia: 1996), pp. 1414-1421, 2198-2199.
Ahmed Mumtaz
Anaebonam Aloysius O.
Clemente Emmett
Mendes Robert W.
Ascent Pharmaceuticals, Inc.
Venkat Jyothsan
LandOfFree
Composition and process for prevention and treatment of cutaneou does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and process for prevention and treatment of cutaneou, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and process for prevention and treatment of cutaneou will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1833392